Feed aggregator
DeepGreenX and Sente Ventures Announce Framework Agreement for $25 Billion Green Infrastructure Investment Program
LONDON & NEW YORK--(BUSINESS WIRE)--DeepGreenX Group Inc. (“DeepGreenX,” “DXG,” or the “Company”), an AI-enabled green energy and technology company, and Sente Ventures (“Sente”), today announced a framework agreement for creating a five-year $25 billion strategic investment program (the “Program”) for companies providing solutions for clean energy generation, virtual grids, battery storage, microreactor power, and data center infrastructure, and enabling technologies to support data centers an
PureTech Appoints UBS as UK Corporate Broker
BOSTON--(BUSINESS WIRE)--PureTech Appoints UBS as UK Corporate Broker.
CPRI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capri Holdings Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)---- $CPRI #CPRI--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Capri Holdings Limited (“Capri” or “the Company”) (NYSE: CPRI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Capri secur
AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)---- $AZN #AstraZeneca--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AstraZeneca PLC (“AstraZeneca” or “the Company”) (NASDAQ: AZN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca